Special Announcement - Now Screening for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for an FDA-approved stem cell clinical trial for knee arthritis. Our clinic is now screening patients for this trial. Contact us at 312-475-1893 for details. Click here to learn more.

Updates in Regenerative Medicine

“The Future of Everything covers the innovation and technology transforming the way we live, work and play” according to Laura Landro in her article published September 9, 2021, in the Wall Street Journal wherein the headline reads “A Knee or Hip Replacement Without Surgery? It’s on the Horizon”. I have been working to that end for the past ten years; and while we are not there yet, progress is being made.

Actually, I have several successful anecdotes using stem cells as featured in my Blogs. In addition, with the understanding that Platelet Rich Plasma is a generic term, our recent patient review found that the proprietary approach we have adopted provides prolonged pain relief up to 18 months post-injection in the presence of painful knee arthritis. Our proprietary PRP injections outperformed corticosteroids and hyaluronic acid.

On October 1, 2021, The American Academy of Orthopedic Surgeons will hold an all-day webinar: Orthobiologics in Non-Surgical Treatment of Knee Osteoarthritis: Risks and Benefits. The AAOS has finally immersed itself in Regenerative Skeletomuscular Medicine and is providing leadership in the research and evidence-based care of an arthritic joint. Just as the FDA on May 31, 2021, put an end to the clinics and pharma companies failing to comply with the law, so too will the patient seeking to postpone or avoid a joint replacement for an arthritic joint be assured of a scientific reason for a biologic application by choosing a Board-Certified Orthopedic Surgeon using Orthobiologics.

Prevention and Treatment of Arthritis | A View to the Future

Next, I would like to introduce you to the possible future of pharmacologic management of arthritis both from the standpoint of prevention and treatment. Senolytics are a class of drugs that selectively clear senescent cells; the drugs target the fundamental aging mechanisms that are “Root Cause” contributors to multiple disorders including, but not limited to osteoarthritis. These drugs are now being used in clinical trials; for instance, In Sweden, a trial for injected Nutlin3a for osteoarthritis. The Senolytics are a whole new world; as we can learn from research at the Mayo Clinic on this subject.

I digress, so I will return to the subjects of reversing your pain and altered function imposed by an arthritic or injured joint. To explore an evidence-based biologic/stem cell/growth factor/structural approach to your arthritic joint, visit my website at www.sheinkopmd.com

A better approach is to schedule an office visit by calling (312) 475-1893 and learn about our full menu of biologic options and become aware of new clinical trial opportunities.

Pin It on Pinterest

Share This